Mode
Text Size
Log in / Sign up
N/A N=94 Treatment

Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery

Vascular Diseases · Peripheral Arterial Disease · Hemodialysis Access Failure (Disorder) · Carotid Artery Diseases · Abdominal Aortic Aneurism

Enrolled (actual)
94
Serious AEs
12.8%
Results posted
Oct 2024
Primary outcome: Primary: Incidence of Central Neurologic Events — 2 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PhotoFix (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Artivion Inc.
Primary completion
Jul 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Incidence of Central Neurologic Events
2
PRIMARY
Primary Patency
16
SECONDARY
Overall Survival
94
SECONDARY
All-Cause Re-operation Rate
1
SECONDARY
Device-Related Re-operation Rate
SECONDARY
Explant Rate
SECONDARY
Adverse Event Rate
28
SECONDARY
Restenosis Rate
4
SECONDARY
Secondary Patency

Summary

The objective of this post-market clinical follow-up study is to evaluate the clinical outcomes of patients receiving PhotoFix as a patch within a vascular repair or reconstruction procedure.

Eligibility Criteria

Inclusion Criteria

  • Patient is undergoing a vascular procedure which falls within the indications for use and requires the use of PhotoFix Decellularized Bovine Pericardium
  • Patient's surgery is anticipated to occur within 60 days of consent
  • Patient is ≥18 years old
  • Patient is willing and able to comply with the protocol and follow up period
  • Patient is willing and able to give written informed consent

Exclusion Criteria

  • Patient's procedure is a revision of a prior arteriotomy or venotomy
  • Patient's procedure requires multiple vascular patches in anatomically distinct regions or other prosthetics (e.g. stents)
  • Patient has a medical history of abnormal coagulopathy, bleeding, or thromboembolic disease
  • Patient has a medical history of severe immunodeficiency disease
  • Patient has a medical history of cancer
  • Patient has severe visceral disease in heart or active liver disease or icterus
  • Patient has a history of cerebrovascular accident (completed stroke) within 3 months of planned surgery
  • Patient has a history of atrial fibrillation and requires a patch for carotid endarterectomy repair
  • Patient has an active or potential infection at the surgical site
  • Patient has used or plans to use immunomodulatory drugs for ≥ 6 months
  • Patient has a sensitivity to products of bovine origin
  • Patient is currently enrolled in another study
  • Patient has a life expectancy of less than 12 months
  • Patient is pregnant or breastfeeding or planning on becoming pregnant or unwilling to use medically acceptable methods of birth control
  • Patient's procedure is emergent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03669042). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search